News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,352 Results
Type
Article (8016)
Company Profile (142)
Press Release (478193)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166736)
Career Advice (302)
Deals (25738)
Drug Delivery (7)
Drug Development (52866)
Employer Resources (14)
FDA (9760)
Job Trends (8567)
News (238192)
Policy (17891)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33140)
ALS (114)
Alzheimer's disease (988)
Antibody-drug conjugate (ADC) (286)
Approvals (10412)
Artificial intelligence (341)
ASCO (159)
Autoimmune disease (225)
Automation (29)
Bankruptcy (263)
Belgium (2)
Best Places to Work (6952)
BIO (36)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (116)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (522)
Cancer (3799)
Cardiovascular disease (228)
Career advice (242)
Career pathing (1)
CAR-T (181)
CDC (1)
CDMO (21)
Celiac Disease (1)
Cell therapy (494)
Cervical cancer (35)
Clinical research (48035)
Collaboration (1292)
Commercialization (3)
Compensation (1540)
Complete response letters (34)
COVID-19 (760)
CRISPR (64)
C-suite (814)
Cystic fibrosis (87)
Data (5926)
Denatured (4)
Depression (107)
Dermatology (73)
Diabetes (362)
Diagnostics (4226)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (161)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (168)
Earnings (73755)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88166)
Executive appointments (719)
FDA (12518)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (962)
Gene editing (126)
Generative AI (11)
Gene therapy (336)
GLP-1 (295)
Government (944)
Grass and pollen (2)
Guidances (281)
Healthcare (9364)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (70)
Immunology and inflammation (108)
Immuno-oncology (62)
Indications (167)
Infectious disease (953)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (265)
Interviews (41)
IPO (12389)
IRA (2)
Job creations (1967)
Job search strategy (232)
JPM (1)
Kidney cancer (17)
Kidney disease (46)
Layoffs (59)
Legal (5194)
Licensing (22)
Liver cancer (45)
Longevity (20)
Lung cancer (550)
Lymphoma (260)
Machine learning (29)
Management (3)
Manufacturing (582)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8681)
Medtech (8842)
Mergers & acquisitions (14418)
Metabolic disorders (736)
mRNA (65)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1886)
NextGen: Class of 2026 (3147)
Non-profit (843)
Obesity (234)
Opinion (10)
Ovarian cancer (163)
Pain (179)
Pancreatic cancer (209)
Parkinson's disease (208)
Partnered (12)
Patents (506)
Patient recruitment (534)
Patient selection (7)
Peanut (32)
People (41382)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15515)
Phase 2 (21458)
Phase 3 (14467)
Pipeline (7845)
Policy (18)
Postmarket research (1559)
Preclinical (6557)
Press Release (34)
Prostate cancer (193)
Psychedelics (8)
Radiopharmaceuticals (195)
Rare diseases (596)
Real estate (3023)
Recruiting (6)
Regenerative medicine (5)
Regulatory (14986)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (166)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (320)
Venture capital (17)
Weight loss (75)
Women's health (90)
Date
Today (73)
Last 7 days (318)
Last 30 days (1453)
Last 365 days (19090)
2026 (13989)
2025 (19251)
2024 (22974)
2023 (26539)
2022 (34586)
2021 (37150)
2020 (33468)
2019 (23239)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24247)
2014 (21679)
2013 (18127)
2012 (20221)
2011 (20426)
2010 (20332)
Location
Africa (227)
Alabama (80)
Alaska (2)
Arizona (312)
Arkansas (10)
Asia (17959)
Australia (2093)
California (12448)
Canada (3268)
China (555)
Colorado (505)
Connecticut (430)
Delaware (217)
Europe (24642)
Florida (1872)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (737)
India (53)
Indiana (326)
Iowa (16)
Japan (432)
Kansas (104)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1237)
Massachusetts (8147)
Michigan (315)
Minnesota (574)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (60)
New Jersey (2723)
New Mexico (12)
New York (2918)
North Carolina (1322)
North Dakota (4)
Northern California (6263)
Ohio (298)
Oklahoma (14)
Oregon (16)
Pennsylvania (2312)
Puerto Rico (24)
Rhode Island (30)
South America (402)
South Carolina (78)
South Dakota (1)
Southern California (5187)
Tennessee (125)
Texas (2033)
United States (40334)
Utah (377)
Vermont (1)
Virginia (159)
Washington D.C. (39)
Washington State (961)
West Virginia (1)
Wisconsin (76)
Wyoming (1)
486,352 Results for "coregen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CoRegen, Inc. Receives FDA Clearance to Advance CRG-150 into Phase 1/2a Clinical Trials, Pioneering a New Frontier in Cell Therapy for Multiple Solid Tumor Types
July 7, 2026
·
4 min read
Press Releases
CoRegen, Inc. Publishes Promising New Data Highlighting SRC-3 Engineered Regulatory T Cells as New Immunotherapy Platform
March 17, 2026
·
4 min read
Press Releases
CoRegen, Inc. Closes More Than $93 Million Financing
July 10, 2025
·
3 min read
Press Releases
CoRegen Appoints Globally Recognized Surgeon-Scientist Bert O’Malley Jr. to its Board of Directors
December 23, 2025
·
4 min read
Press Releases
CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer
August 1, 2025
·
3 min read
Press Releases
CoRegen, Inc. Strengthens Leadership Team with the Appointments of Sonja Nelson as Chief Financial Officer and Peter Gelinas as Chief Technical Officer
September 11, 2025
·
4 min read
Business
CoRegen Appoints Edward J. Benz, M.D., to its Board of Directors
CoRegen, a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, announced the appointment of Edward J. Benz, M.D., to its Board of Directors.
November 16, 2023
·
4 min read
Lone Star Bio
CoRegen Inc. Announces Publication of Preclinical Research Demonstrating Treatment with Modified Tregs Eliminates Tumors and Prevents Recurrence Without Side Effects
CoRegen announced today the publication of research, titled, “Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasion,” in the peer-reviewed journal Proceedings of the National Academy of Sciences (PNAS).
June 1, 2023
·
4 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
1 of 48,636
Next
